Home › PTC Therapeutics Expands Access For Translarna (Ataluren)
 

Keywords :   


PTC Therapeutics Expands Access For Translarna (Ataluren)

2014-11-05 07:13:37| drugdiscoveryonline Home Page

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that Translarna™ (ataluren) has been approved to be included in the list of drugs reimbursable by the Italian National Health System under Law 648/96

Tags: access expands therapeutics ptc

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
25.09Atlantic Tropical Weather Outlook
25.09Tropical Storm Helene Public Advisory Number 7A
25.09Summary for Tropical Storm Helene (AT4/AL092024)
25.09Eastern North Pacific Tropical Weather Outlook
25.09Sickness benefit claimants should look for work - PM
25.09Boeing workers not interested in 30% pay rise - union
25.09Tropical Storm Helene Potential Storm Surge Flooding Map
25.09Tropical Storm Helene Probabilistic Storm Surge Graphics
More »